The End of the Assad Regime in Syria

ZOOMER SQUAD: OLDER CANADIANS SEE INCOME IMPROVEMENT SINCE 1976, BUT LAG BEHIND WORKING-AGE ADULTS SINCE THE 1990S Libby Znaimer is joined by Anthony Quinn, Chief Operating Officer of CARP, Bill VanGorder, Advocacy and Education Officer of CARP and John Wright, veteran pollster. A new Canadian Cancer Society report highlights the financial strain of cancer diagnoses in Canada, with patients and families facing an average cost of $33,000. While Ontario recently announced extra support for caregivers, questions remain about its effectiveness. Meanwhile, the holiday GST break on some food items has faced widespread criticism. SYRIA'S UNCERTAIN FUTURE POST-ASSAD REGIME Libby is joined by Dr. Amos Guiora, Professor of Law at the University of Utah and a former legal advisor to the IDF in Gaza and Dr. Elliot Tepper, Professor of International Relations at Carleton University. The Assad regime in Syria collapsed after rebel forces, led by Hayat Tahrir al-Sham, seized Damascus. The group, once linked to ISIS and Al-Qaeda, is still considered a terrorist organization by the U.S. and Western nations. This marks a major setback for Iran and Russia, with uncertain regional implications. A NEW STUDY REVEALS THE STAGGERING COSTS CANCER PATIENTS FACE Libby is joined by Dr. Jennifer Gillis, Director of Surveillance for the Canadian Cancer Society. The financial burden of cancer is significant, with total costs to society projected at $37.7 billion in 2024. This includes $30.2 billion in health system expenses and $7.5 billion for patients and caregivers. In the first year after diagnosis, lifetime costs for patients and caregivers average nearly $33,000.